Company Quick10K Filing
Capitol Investment IV
10-K 2019-12-31 Filed 2020-03-16
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-07-31
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-04
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-27
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-09-27
8-K 2020-03-12
8-K 2020-03-11
8-K 2020-03-02
8-K 2020-02-27
8-K 2019-11-14
8-K 2019-11-11
8-K 2019-11-05
8-K 2019-10-29
8-K 2019-09-23
8-K 2019-09-10
8-K 2019-09-03
8-K 2019-08-22
8-K 2019-08-09
8-K 2019-07-29
8-K 2019-07-26
8-K 2019-07-22
8-K 2019-07-16
8-K 2019-07-11
8-K 2019-06-04
8-K 2019-05-15
8-K 2019-05-13
8-K 2019-05-07
8-K 2019-04-07
8-K 2019-03-22
8-K 2019-02-28
8-K 2018-11-07
8-K 2018-10-03
8-K 2018-08-03

Capitol Investment IV Financials

CIC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash23594850274539421
Accounts Receivable
Inventory
PP&E
Assets313403,613403,109404,013405,089406,445
Accounts Payable
Long-Term Debt
Liabilities29314,16314,26414,21314,26814,194
Stockholders' Equity205,0005,0005,0005,0005,000
Income Statement ($'000)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue6060
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income-5-167-6059551,0201,431
Cash Flow ($'000)2017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-5-262-441-507-351
Cash Investing07500
Cash Financing240403,475-5